iRhythm Technologies (IRTC) Stock: Buy, Sell, or Hold?
IRTC - iRhythm Technologies, Inc
$110.37
-0.68 (-0.61%)
▼
5d:
-0.01%
30d:
-9.89%
90d:
-12.43%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 29, 2026
25d
Get Alerted When IRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IRTC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: IRTC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$59.08
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$36.69
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRTC is currently trading at $110.37, which is considered slightly low relative to its 30-day fair value range of $110.65 to $120.81. From a valuation perspective, the stock is trading at a discount (Forward PE: 90.9) compared to its historical average (118.9). Remarkably, the market is currently pricing in an annual earnings decline of 8.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IRTC is showing sideways momentum. The price is currently testing key support at $107.92. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IRTC scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $176.14 (+59.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IRTC is showing sideways momentum. The price is currently testing key support at $107.92. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: IRTC scores 64/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $176.14 (+59.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$110.65 -
$120.81
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
90.5%
Protect Your Profits
Holding IRTC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (64/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 59.6% below Wall St target ($176.14)
- CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$110.65 -
$120.81
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$107.92
Resistance Level
$117.03
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
90.94
Wall Street Target
$176.14
(+59.6%)
Revenue Growth (YoY)
20.1%
Profit Margin
-1.7%
Valuation Discount vs History
-8.6% cheaper
PE vs Historical
90.9 vs 118.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.6%
(market-implied from PE analysis)
1-Year Target
$100.88
(-9%)
2-Year Target
$92.20
(-17%)
3-Year Target
$84.27
(-24%)
3-Yr Target (if PE normalizes)
(PE: 91→119)
$110.18
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 90.9, Growth: 107.6%)
$372.50
(+238%)
Base:
(SPY PE: 20.4, Growth: 107.6%)
$83.56
(-24%)
Bear:
(PE: 17.3, Growth: 107.6%)
$71.02
(-36%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 90.9 to 118.9
Stabilization Target:
$144.30
(+30.7%)
PE Expansion Potential:
+30.7%
Share & Embed Analysis
Last updated: October 03, 2026 10:46 AM ET
Data refreshes hourly during market hours. Next update: 11:46 AM
Data refreshes hourly during market hours. Next update: 11:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 58 HOLD |
Advanced IRTC Option Strategies
Professional options setups generated by AI based on today's IRTC price and gamma walls.
